Text full multimedia monochrome

First time here?

Find out more about how The Lecture List works.

Coronavirus situation update

Our lecture organisers may or may not have had time to update their events with cancellation notices. Clearly social gatherings are to be avoided and that includes lectures. STAY AT HOME FOLKS, PLEASE.


Find out what you can do to keep The Lecture List online

Envy: Changing Faces – the rise of plastic surgery

The first in our series exploring the Seven Deadly Sins, Dr Nichola Rumsey and Dr Jeremy Tinkler will discuss envy.

Is how we look who we are? Psychologist Dr Nichola Rumsey, Research Director at The Centre for Appearance Research (CAR), University of the West of England, will discuss what drives so many people to have dramatic plastic surgery, and the psychological implications of disfigurement. She will be joined by Jeremy Tinkler from the Medicines and Healthcare products Regulatory Agency (MRHA), a toxicologist who investigates the safety of breast implants in the UK. As MHRA’s Principle Specialist in Biosciences and Implants, he was immersed in the controversy over silicone gel breast implants during the 1990s and then investigated the safety of other types of breast implant, some of which were withdrawn from the market or explanted from women. He will describe the risks, both real and imagined, that emerged and explore the factors that turned pride into outrage.


Professor Nichola Rumsey | talks | www
Dr Jeremy Tinkler | talks


Date and Time:

27 November 2006 at 6:00 pm


1 hour



Centre for Life
Times Square
Newcastle Upon Tyne
0191 243 8292

More at Centre for Life...




Available from:

Booking not required for this event. Doors open at 5:15pm, and we advise arriving early to secure a seat.

Additional Information:

For further information e-mail lectures@life.org.uk or call 0191 243 8292

Register to tell a friend about this lecture.


If you would like to comment about this lecture, please register here.


Any ad revenue is entirely reinvested into the Lecture List's operating fund